May 24, 2022
Conquer Cancer, the ASCO Foundation, is pleased to announce the recipients of its awards supporting researchers with projects that span many areas of cancer care, including precision medicine, palliative care, and breast cancer. These awards will be given in conjunction with the 2022 ASCO Annual Meeting being held in Chicago, IL, on June 3-7. Conquer Cancer Grants & Awards support oncology professionals at every career stage, medical students, and residents to help accelerate research breakthroughs and build an oncology workforce that more fully represents the diversity of individuals with cancer. At the 2022 ASCO Annual Meeting, more than $12 million will be awarded to more than 400 recipients representing 32 countries around the world.
“Thank you to the generous Conquer Cancer donors who are supporting the remarkable group of individuals we are honoring. It is these rising leaders whose projects offer a range of creative approaches to cancer care, who are working to accelerate breakthrough research and empower people everywhere to conquer cancer,” said Conquer Cancer Board chair Howard A. Burris III, MD, FACP, FASCO. “While these grants and awards provide funding to explore inventive ideas and opportunities to build meaningful careers, they also offer great hope to our patients.”
Advanced Clinical Research Awards for Diversity and Inclusion in Breast Cancer
The Advanced Clinical Research Award (ACRA) for Diversity and Inclusion aims to increase diversity in the oncology workforce and breast cancer research. The 2022 Conquer Cancer - Breast Cancer Research Foundation® ACRA recipients are Rachel Jimenez, MD, of Massachusetts General Hospital, and Samilia Obeng-Gyasi, MD, MPH, of Ohio State University. Dr. Jimenez will receive $450,000 to further the project “A Randomized Clinical Trial to Study the Impact of Emerging Radiation Techniques on Cardiac Injury in the Treatment of Women With Breast Cancer,” and Dr. Obeng-Gyasi will receive $450,000 to further the project “Examining Allostatic Load as a Mediator of the Relationship Between Genetic Ancestry and Treatment Completion.”
Research Professorship for Diversity and Inclusion in Breast Cancer
The Research Professorship for Diversity and Inclusion in Breast Cancer provides flexible funding to an outstanding researcher who has made and is continuing to make significant contributions that have changed the direction of breast cancer research and who provides mentorship to junior researchers. The 2022 Conquer Cancer - Breast Cancer Research Foundation® Research Professorship recipient is Mylin A. Torres, MD, of Emory University. Dr. Torres will receive $500,000 over the next 5 years to further the project “Genetic Determinants of Treatment-Related Comorbidities, Poor Treatment Adherence, and Worse Survival Among Black Patients With Early-Stage Breast Cancer.”
Career Development Awards
The Career Development Award (CDA) is a 3-year grant that funds clinical investigators in the first to third year of faculty appointment to establish an independent clinical cancer research program. At the 2022 ASCO Annual Meeting, 21 promising clinicians will be presented with CDAs.
Young Investigator Awards
The Young Investigator Award (YIA) provides research funding to promising young physicians during the final years of training to support the transition to a faculty appointment and to encourage quality research in clinical oncology. At the 2022 ASCO Annual Meeting, 95 investigators were selected to receive YIAs.
Global Oncology Young Investigator Awards
The Global Oncology Young Investigator Award (GO YIA) provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation of researchers to address global health needs. At the 2022 ASCO Annual Meeting, five investigators were selected to receive GO YIAs.
International Development and Education Awards
The International Development and Education Award (IDEA) provides support for early-career oncologists in low- and middle-income countries and facilitates the sharing of knowledge between these oncologists and ASCO members who serve as scientific mentors to each recipient. This year, eight early-career oncologists will be awarded with IDEAs.
International Development and Education Awards in Palliative Care
The International Development and Education Award in Palliative Care (IDEA-PC) provides medical education in palliative care, assists with career development, and helps establish strong relationships with leading ASCO members in the field of palliative care who serve as scientific mentors to each recipient. This year, three researchers will be awarded with IDEA-PCs.
Medical Student Rotation for Underrepresented Populations
The Medical Student Rotation (MSR) provides support for clinical or clinical research oncology rotations to U.S. medical students from populations underrepresented in medicine who are interested in pursuing oncology as a career. This year, 28 students will be awarded with MSRs.
Annual Meeting Research Awards
The Annual Meeting Research Award (AMRA) offers an opportunity for non-oncology medical residents from populations underrepresented in medicine to meet oncologists at the ASCO Annual Meeting and to learn more about career options in the field of oncology. This year, eight recipients will receive the AMRA.
Research Professorship: This award is generously supported by Breast Cancer Research Foundation®.
ACRA: These awards are generously supported by Breast Cancer Research Foundation®.
CDA: These awards are generously supported by Anonymous, AbbVie, Inc., ASCO Employees, AstraZeneca, Breast Cancer Research Foundation®, Gilead Sciences, Inc., Israel Cancer Research Fund, Janssen Research & Development, LLC, Eugene and Janet Lerner Family Foundation, Lilly, Walther Cancer Foundation, and Generous Supporters of the Women Who Conquer Cancer.
YIA: These awards are generously supported by Anonymous, AbbVie, Inc., AbbVie Oncology, American Association for Cancer Research, American Society of Clinical Oncology, ASCO’s State Affiliate Council, Association for Value-Based Cancer Care, Association of Northern California Oncologists, AstraZeneca, Dr. Charles M. Baum and Carol A. Baum, Sumeet and Sumeeta Bhatia, Boehringer Ingelheim Pharmaceuticals, Inc., Nina Lesavoy Brady, Breast Cancer Research Foundation®, Bristol Myers Squibb, Howard A. Burris, III, MD, and Karen Y. Burris, Casdin Family Foundation, Choose Chicago, Friends, Colleagues and Family of Marc L. Citron, MD, Mr. and Mrs. Charles and Trisha Elcan, Exact Sciences Corporation, Florida Society of Clinical Oncology, Dr. and Mrs. Thomas F. Frist, Jr., Gateway for Cancer Research, Generous Supporters of the Evening to Conquer Cancer, GlaxoSmithKline Oncology, The Hearst Foundation, Inc., Janssen Oncology, Journal of Clinical Oncology, Alan and Judith Kaur, Helen L. Kay Charitable Trust, Miodrag Kukrika, MD, LA Kunkel Foundation, The John and Elizabeth Leonard Family Foundation, Lilly, Lobular Breast Cancer Alliance, Massachusetts Society of Clinical Oncologists, Merck & Co., Inc., Georgia and Michael Michelson, Michiana Hematology Oncology, New Rhein, LLC, Nebraska Oncology Society, Pfizer Oncology, The Phase Foundation, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., The QuadW Foundation, The Norman & Ruth Rales Foundation, Thomas G. Roberts, Jr., MD, FASCO, and Susan M. DaSilva, DNP, Colleagues, Friends, and Family of Dr. Gladys Rodriguez and Dr. Narjust Duma, Sapiente Family Foundation, Sarah Cannon Research Institute, Aaron and Barbro Sasson, Susan & Teresa Schwab Ovarian Cancer Research Foundation, Shanken Family Foundation, The Sontag Foundation, Strike 3 Foundation, Swim Across America, Tap Cancer Out, Texas Society of Clinical Oncology, Tomasello Family, Triple Negative Breast Cancer Foundation, Vaniam Group LLC, The Vose Family, Women Leaders in Oncology LLC, Generous Supporters of the Women Who Conquer Cancer, and The Richard H. Yearick Foundation.
GO YIA: These grants are generously supported by Bristol Myers Squibb, Choose Chicago, and Mission Endowment of Conquer Cancer, the ASCO Foundation.
IDEA: These grants are generously supported by Mission Endowment of Conquer Cancer, the ASCO Foundation.
IDEA-PC: These awards are generously supported by the Mission Endowment of Conquer Cancer, the ASCO Foundation.
MSR: These awards are generously supported by AstraZeneca, Bristol Myers Squibb, EQRx, Gilead Sciences, Inc., Novartis, Pfizer Oncology, Taiho Oncology, and Truist Charitable Fund.
AMRA: These awards are generously supported by the Association of Northern California Oncologists, Gilead Sciences, Inc., and Massachusetts Society of Clinical Oncologists.
All listings ae as of May 24, 2022, and reflect institutions at the time of award. Browse the complete list of funding opportunities and recipients.